Extra inner R7 photoreceptors in many ommatidia.
One copy causes mild external eye roughening, two copies enhance the roughening. Dosage-dependent (two or more copies of P{sev-svp2}) transformation of cone cells into R7 photoreceptors and at a lower frequency R7 cells into outer photoreceptors. Also an increasing number of ommatidia have malformed and collapsed lenses.
Rough eye phenotype. Transformation of cone cells towards R7 neurons. Increased copies of P{sev-svp1} cause ommatidia to contain seven or more outer photoreceptors and one or more R7 cells, this represents a transformation of R7 to an outer photoreceptor.
Transformation of cone cells and photoreceptor cell 7 to photoreceptor cell 7 or outer photoreceptors.
svp2.sev has eye photoreceptor cell phenotype, enhanceable by mblA.sev
svp2.sev has phenotype, enhanceable by sevS11.Tag:MYC
svp2.sev has phenotype, enhanceable by RasGAP1rI533
svp2.sev has phenotype, enhanceable by Ras85DV12.sev
svp2.sev has phenotype, enhanceable by Raf::tor12D.hs.sev
svp2.sev has eye photoreceptor cell phenotype, suppressible by mblk05507b
svp2.sev has eye photoreceptor cell phenotype, suppressible by mblE27
svp2.sev has eye phenotype, suppressible by TfIIA-SE73
svp2.sev has phenotype, suppressible by phylodin17L1
svp2.sev has phenotype, suppressible by phylodin3G6
svp2.sev has phenotype, suppressible by cswEsev1A-eOP
sina1/sina3, svp2.sev has photoreceptor cell R7 phenotype
Phenotype can be suppressed by mblk05507b and mblE27, most ommatidia have a wild-type appearance. Phenotype can be enhanced by mblA.sev, many ommatidia contain extra photoreceptors of the outer type, up to 11 outer photoreceptors instead of the normal 6.
TfIIA-SE73 suppresses the rough eye phenotype of sevS11.T:Hsap\MYC, phl::tor12D.hs.sev, Ras85DV12.sev, rlSem and svp2.sev.
Phenotype depends on C terminal portion of the protein, see svpsev.ΔMlu, svpsev.ΔSal and svpsev.ΔSal.
Cone cell transformation can be dominantly suppressed by mutations in components of the Ras85D signal transduction cascade. Mutations in negative regulators of Ras85D activity act as dominant enhancers.